BRUSSELS, July 28 UCB today announced the results of a 6-month, randomized, double-blind, placebo-controlled clinical study, published in the journal Movement Disorders, showing that Neupro® ...

BRUSSELS, June 18 /PRNewswire-FirstCall/ --The first data to show that Neupro® (rotigotine transdermal system) significantly improved wellbeing and daily activities ...

Latest safety and efficacy results for rotigotine in the treatment of moderate to severe restless legs syndrome presented at major North American neurology congress Brussels (Belgium), 13 April 2010, ...

Brussels (Belgium), 16 June – 0700 (CET) – UCB announced today efficacy and safety data from a Phase 3 study evaluating NEUPRO® (rotigotine transdermal patch) in the treatment of patients in China ...

recommended to taper treatment. Neupro(R) contains sodium metabisulphite, a sulphite that may cause allergic-type reactions including anaphylactic symptoms and life threatening or less severe ...

A study supported by the Alzheimer's Drug Discovery Foundation and published today in JAMA Network Open provides the first evidence that rotigotine, a drug that acts on dopamine transmission in the ...

UCB announced that Neupro (rotigotine transdermal system) is now available as a once-daily patch for the treatment of signs and symptoms of early and advanced stage idiopathic Parkinson’s disease (PD) ...

Please provide your email address to receive an email when new articles are posted on . “Some early attempts have been carried out using dopaminergic drugs, such as L-dopa or selegiline, in samples of ...

"While further study is needed to confirm, this post hoc exploratory analysis from a randomized double blind placebo controlled study suggested beneficial effects of rotigotine transdermal system on ...

A study supported by the Alzheimer's Drug Discovery Foundation and published today in JAMA Network Open provides the first evidence that rotigotine, a drug that acts on dopamine transmission in the ...

Atlanta, April 13th, 2010 – New data presented at the 62nd American Academy of Neurology annual meeting in Toronto, Canada, showed that patients with moderate to severe Restless Legs Syndrome (RLS) ...

Neupro® (Rotigotine Transdermal System) Significantly Improved Wellbeing and Daily Activities Impaired Due to Limb Pain Associated With Restless Legs Syndrome - Data presented at major international ...